Activation of Nrf2/HO-1 by Peptide YD1 Attenuates Inflammatory Symptoms through Suppression of TLR4/MYyD88/NF-κB Signaling Cascade

In this study, we investigate the immunomodulatory effects of a novel antimicrobial peptide, YD1, isolated from Kimchi, in both in vitro and in vivo models. We establish that YD1 exerts its anti-inflammatory effects via up-regulation of the Nrf2 pathway, resulting in the production of HO-1, which suppresses activation of the NF-κB pathway, including the subsequent proinflammatory cytokines IL-1β, IL-6, and TNF-α. We also found that YD1 robustly suppresses nitric oxide (NO) and prostaglandin E2 (PGE₂) production by down-regulating the expression of the upstream genes, iNOS and COX-2, acting as a strong antioxidant. Collectively, YD1 exhibits vigorous anti-inflammatory and antioxidant activity, presenting it as an interesting potential therapeutic agent.     

Chrysin,Apigenin and Acacetin Inhibit Tumor Necrosis Factor-Related Apoptosis—Inducing Ligand Receptor-1 (TRAIL-R1) on Activated RAW264.7 Macrophages

Expression level of Tumor Necrosis Factor—related apoptosis—inducing ligand (TRAIL) receptors is one of the most important factors of TRAIL-mediated apoptosis in cancer cells. We here report for the first time data concerning TRAIL-R1 and TRAIL-R2 receptor expression on RAW264.7 macrophages. Three substances belonging to flavones: chrysin, apigenin and acacetin which differ from their substituents at the 4'' position in the phenyl ring were used in assays because of the variety of biological activities (e.g., anticancer activity) of the polyphenol compounds. The expression of TRAIL-R1 and TRAIL-R2 death receptors on non-stimulated and LPS (lipopolysaccharide)-stimulated macrophages was determined using flow cytometry. We demonstrate that RAW264.7 macrophages exhibit TRAIL-R1 surface expression and that the tested compounds: chrysin, apigenin and acacetin can inhibit TRAIL-R1 death receptor expression level on macrophages.     

Analysis of Phytochemical Composition of Camellia oleifera Oil and Evaluation of its Anti-Inflammatory Effect in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages

In China, Camellia oleifera oil (COO) is not only a common edible oil but also a traditional remedy widely applied to ameliorate a variety of illnesses associated with inflammation, such as mouth ulcers, thrush, eczema, etc. However, there has been a lack of relevant biological research on the anti-inflammatory capacity of COO, and the specific bioactive lipid phytochemicals contributing to the anti-inflammatory effect need further research. In this study, the RAW 264.7 macrophages model was used to investigate the anti-inflammatory capacity of COO. Our data showed that 33–200 μg/mL COO markedly inhibited the lipopolysaccharide lipopolysaccharide (LPS)-stimulated nitric oxide (NO.) secretion via the suppression of Nos2 and Cox-2 expression. The enzyme immunoassay confirmed that COO also exhibited a strong suppressive effect on the expression of proinflammatory cytokines such as Tnf-α and Il-6. To further explore the correlation between the anti-inflammatory effects and the lipid phytochemicals in COO, 10 samples were collected and screened for their chemical compositions. It was interestingly demonstrated that the polyphenol extracts of COO play a vital role in its anti-inflammatory properties. In addition, an oil-in-water (O/W) emulsion-based system was also developed to deliver the liposoluble COO into the cells, and the feasibility of this system was confirmed. Our research confirms the anti-inflammatory potential of COO and highlights that the main functional ingredient is polyphenol extracts. This may provide a scientific basis for the comprehensive utilization and development of COO and related functional foods.     

On the use of the Balancing Method for calculating component RAW involving CCFs in SSC categorization

In this paper, it is revived and suggested that the method called ‘Balancing Method’ could be used in deriving a component risk achievement worth (RAW) from the basic event RAWs including common cause failure RAW, and the Balancing Method is compared with the other methods. Since the component RAW value generated by the Balancing Method very closely resembles the real component RAW value, the Balancing Method could be widely used in the calculation of the component RAW which plays a key role in the risk informed regulation and applications.     

兜唇石斛发酵多肽Asp-Asp-Asp-Tyr和Asp-Tyr- Asp-Asp对LPS诱导RAW264.7细胞的抗炎作用

为了研究兜唇石斛发酵多肽Asp-Asp-Asp-Tyr（DDDY）、Asp-Tyr-Asp-Asp（DYDD）对LPS诱导的RAW264.7巨噬细胞抗炎活性。以合成的兜唇石斛发酵多肽为研究对象,采用噻唑蓝法筛选增殖活性最高的发酵多肽浓度,通过中性红吞噬实验和倒置显微镜观察发酵多肽对细胞的吞噬作用和分化形态变化,使用ELISA试剂盒测定细胞中NO及细胞因子IL-1β、IL-6、IL-10和肿瘤坏死因子TNF-α的分泌量。结果表明：12.5、25、50和100 μg/mL四组质量浓度的发酵多肽对细胞无毒性并有增殖作用;100 μg/mL的DDDY和DYDD和1 μg/mL的LPS处理可以激活细胞,增强细胞吞噬能力,相对吞噬率为2.05%、1.97%和2.19%;构建LPS诱导的RAW264.7细胞炎症模型,发现两种发酵多肽处理有效抑制细胞分化,使细胞恢复正常形态;抑制细胞NO分泌能力,100 μg/mL DDDY和DYDD处理组的NO分泌能力降低到LPS组的0.41倍和0.49倍;并且对抑炎细胞因子分泌能力的提高和促炎细胞因子的降低有显著效果,均表现出剂量反应关系。由此可知,DDDY和DYDD对LPS诱导的RAW264.7巨噬细胞炎症反应具有抗炎作用,为后面探究发酵多肽的炎症机制提供理论支持。     

Antioxidant and nitric oxide production inhibitory activities of galacturonyl hydroxamic acid

The self-prepared pectin hydroxamic acid has been reported to have antioxidant activities [Yang, S. S., Cheng, K. D., Lin, Y. S., Liu, Y. W., & Hou, W. C. (2004). Pectin hydroxamic acids exhibit antioxidant activities in vitro. Journal of Agricultural and Food Chemistry, 52, 4270–4273]. In this study, the galacturonic acid (GalA), the monomer unit of the pectin polymer, was esterified with acidic methanol (1 N HCl) at 4 °C with gentle stirring for 5 days to get galacturonic acid methyl ester which was further reacted with alkaline hydroxylamine to get galacturonyl hydroxamic acid (GalA–NHOH). The GalA–NHOH was used to test the antioxidant and antiradical activities in the comparison with GalA. The scavenging activities of GalA–NHOH against DPPH radicals (half-inhibition concentration, IC₅₀, was 82 μM), hydroxyl radicals detected by electron spin resonance (IC₅₀ was 0.227 nM in the comparison with Trolox of 0.433 μM), superoxide radicals (IC₅₀ was 830 μM) were determined. The protection activities of GalA–NHOH against hydroxyl radicals-mediated calf thymus DNA damages, linoleic acid peroxidation and peroxynitrite-mediated dihydrorhodamine 123 oxidations were also investigated. It was found that the GalA–NHOH exhibited dose-dependently antioxidant activity and few or none was found in GalA. The GalA–NHOH was used to evaluate the suppressed activity of nitric oxide (NO) productions of RAW264.7 cells in the presence of lipopolysaccharide (LPS, 100 ng/ml) as inducers. It was found that GalA–NHOH (0.02–0.1 mg/ml) could dose-dependently suppress the NO productions (expressed as nitrite concentrations) in RAW264.7 cells without significant cytotoxicity.     

单增李斯特菌感染RAW264.7细胞转录组差异表达分析

为了探讨单核细胞增生李斯特菌（Listeria monocytogenes,LM）感染前后RAW264.7细胞基因表达谱变化,筛选关键功能基因和通路,为探究其致病机制奠定基础,本研究以感染复数（MOI）10的LM 感染RAW264.7细胞6 h后,提取细胞RNA进行转录组测序,选取感染组与对照组相比差异倍数≥1.5且P<0.05的差异表达基因进行GO和KEGG富集分析,并通过RT-qPCR验证部分差异基因。转录组结果显示RAW264.7细胞在感染LM前后有1 782 个基因差异表达,其中上调为989,下调为793。GO分析结果主要涉及免疫系统过程、免疫反应、细胞程序性死亡调控等。KEGG分析结果显示,显著富集的通路有细胞因子-受体相互作用、肿瘤坏死因子信号通路、IL-17信号通路等。RT-qPCR验证试验结果显示,随机选择的11 个显著差异基因表达倍数趋势与测序结果一致。该研究为进一步深入研究LM的致病机制奠定了基础。